Key statistics
As of last trade, Enanta Pharmaceuticals Inc (9EP:FRA) traded at 9.70, 29.33% above the 52 week low of 7.50 set on Nov 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 10.50 |
---|---|
High | 10.50 |
Low | 9.70 |
Bid | 9.75 |
Offer | 10.40 |
Previous close | 10.20 |
Average volume | 56.67 |
---|---|
Shares outstanding | 21.19m |
Free float | 19.90m |
P/E (TTM) | -- |
Market cap | 244.73m USD |
EPS (TTM) | -5.46 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 18:55 BST.
More ▼
Press releases
- Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With Respiratory Syncytial Virus (RSV)
- Enanta Pharmaceuticals to Participate in Investor Conferences in September
- Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter
- Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ET